Cancer

From solid tumors to metastatic carcinomas and leukemia: cancer is among the most common causes of death and has many faces. Keep reading for latest developments in early detection, staging, therapy and research.

News • Preventive transmission model

How C. diff spreads in a hospital oncology ward

Many cancer treatments leave their recipients immunocompromised and at greater risk of infection. A new transmission model aims to better prevent transmission in hospitals' oncology wards.

News • Intraoperative diagnosis and classification of gliomas

Mass spectrometry helps detect the edges of brain tumors

After surgery of glioma brain tumors, remaining cancerous tissue can contribute to recurrence. To better detect these tissues, researchers have developed a new mass spectrometry-based method.

News • Gynaecologic oncology

Vulvar cancer: New surgical technique can restore the clitoris

Surgery for vulvar cancer can save lives, but also significantly affect a woman's sexual function and quality of life. Now, a new surgical technique makes it possible to restore the clitoris.

News • Fluidic-shear device

Novel cell-collector to improve early detection of ovarian cancer

Early detection of ovarian cancer is difficult as precursor lesions can be microscopic and hard to sample. To address this, researchers developed a handheld device that can gently collect living…

News • Benefits of reduced sugar consumption

Skipping sweets could help protect the gut microbiome during antibiotic therapy

Could a patient's sweet tooth sabotage antibiotic treatment for blood cancer? A study suggests that eating less sugar could protect the microbiome during allogeneic hematopoietic cell transplant.

News • Radiation oncology trial

Tile-based radiation therapy to lower risk of recurrence in brain metastases

Using implanted collagen tiles during brain surgery, a new kind of radiation therapy (TBRT) could significantly lower the risk of recurrence in brain metastases, a new study finds.

News • Oncology

DNA in blood signals cancer risk years ahead

DNA methylation patterns in blood could identify people at high risk of prostate or breast cancer up to eight years before diagnosis, Oxford Population Health researchers report.

News • Onkologie

Tumours use antioxidants to evade immune attack

A Cambridge study reveals how tumours suppress immune responses – and how blocking this mechanism could make immunotherapies effective in more patients.

News • Assessment of spatial configuration

AI scans pathology slides to predict pancreatic cancer recurrence

AI-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery, a new study finds.

News • Unexpected weight loss

Blood test trends may help identify increased risk of cancer

Monitoring blood test trends alongside unexplained weight loss can provide further clues about a patient’s risk of developing cancer, according to a new study.

News • Urologie

Urine test detects 9 in 10 bladder cancers in NHS study

A non-invasive urine test detected more than 9 in 10 bladder cancers in a large NHS study – and could reduce urgent cystoscopies significantly.

News • Impact on healthy tissues uncovered

Study explores cost of childhood chemotherapy

For many childhood cancers, chemotherapy is the only treatment option. A study explores the trade-off between life-saving treatment at a young age, and delayed side effects unfolding over a lifetime.

News • Promising treatment synergies

Pancreatic cancer radiotherapy could also boost immunotherapy

Radiotherapy may be able to do far more than simply destroy tumor cells. A review explores how combining radiotherapy with immunotherapy could improve outcomes for patients with pancreatic cancer.

News • Immunotherapy first, surgery afterwards

Glioblastoma: treatment sequence matters

In glioblastoma, the treatment order matters: a new study shows that administering cell immunotherapy before surgery to remove a brain tumour is significantly more effective than the other way around.

News • Adverse effects of lung cancer treatment

Collateral damage: the thymus in NSCLC radiotherapy

Exposure of the thymus to radiation during lung cancer treatment is linked to an increased risk of the cancer spreading to other parts of the body and overall worse outcomes, a new study finds.

News • Tissue model mimics colonization

'Metastasis-on-a-chip' to advance understanding of cancer spread

Cancer metastasis is responsible for at least two-thirds of cancer deaths. Researchers have developed a multi-organ chip that mimics how cancer cells spread to distant organs to gain new insights.

News • NSCLC immunotherapy response prediction

AI-powered “virtual patient” to advance personalised cancer treatment

On the way to a patient's “digital twin”: A novel, AI-powered virtual patient simulation system integrating multimodal data is designed to advance personalised cancer treatment.

News • Deep visual multi-omics profiling

Digital pathology AI to break down tumor cell populations

Digital pathology and spatial omics could enable researchers to see how a tumor's different cell populations function, opening new perspectives for precision cancer therapy.

Why Germans & Austrians Choose Sheba for TIL Therapy & Melanoma Care

As TIL therapy remains difficult to access across Germany and Austria, Sheba offers more than 15 years of experience, in-house cell manufacturing, and one of the world's leading cellular therapy programs for advanced melanoma.

News • Nanomedicine

Reshaping the gut microbiome to boost chemotherapy

A new study has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, making these nanoparticle-based cancer drugs more effective.

Sheba Is Giving Europeans Greater Access to TIL Therapy for Metastatic Melanoma

As access to TIL therapy remains limited across Europe, Sheba Medical Center combines 15+ years of experience, in-house manufacturing, and pioneering research to advance melanoma and CAR-T therapies.

Dr. Beth Erickson

Showing patients and the medical community what radiation therapy can achieve

The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to its Board of Directors. Beth Erickson, MD, FASTRO, has been elected President of the medical society.

News • Improved tumor response and survival outcomes

Focused ultrasound may enhance chemotherapy for pancreatic cancer

Results from a recently published clinical trial suggest that combining focused ultrasound with chemotherapy may improve tumor response and survival outcomes in patients with pancreatic cancer.

News • Pediatric oncology

"Genomic fingerprints" left by chemotherapy could point to more precise cancer treatments

Chemotherapy of many childhood cancers leaves specific traces in the DNA, a new study finds. These changes could help clinicians spot treatment resistance earlier, before cancer returns or spreads.

News • New insights on TILs

Immune cells in the tumour microenvironment: Better near than far away?

Tumour-infiltrating lymphocytes are key players in cancer immunotherapy. New research explores the role of location in the tumour microenvironment – knowledge that could help improve treatments.

1072 show more articles